South Korea
· Delayed Price · Currency is KRW EASY BIO,Inc. Statistics
Total Valuation
EASY BIO,Inc. has a market cap or net worth of KRW 169.71 billion. The enterprise value is 292.69 billion.
| Market Cap | 169.71B |
| Enterprise Value | 292.69B |
Important Dates
The next estimated earnings date is Thursday, August 14, 2025.
| Earnings Date | Aug 14, 2025 |
| Ex-Dividend Date | Dec 27, 2024 |
Share Statistics
EASY BIO,Inc. has 33.08 million shares outstanding. The number of shares has decreased by -1.60% in one year.
| Current Share Class | 33.08M |
| Shares Outstanding | 33.08M |
| Shares Change (YoY) | -1.60% |
| Shares Change (QoQ) | -0.32% |
| Owned by Insiders (%) | 1.34% |
| Owned by Institutions (%) | 0.32% |
| Float | 16.04M |
Valuation Ratios
The trailing PE ratio is 8.42 and the forward PE ratio is 5.53.
| PE Ratio | 8.42 |
| Forward PE | 5.53 |
| PS Ratio | 0.38 |
| PB Ratio | 1.93 |
| P/TBV Ratio | 9.60 |
| P/FCF Ratio | 10.24 |
| P/OCF Ratio | 8.83 |
| PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 6.70, with an EV/FCF ratio of 17.66.
| EV / Earnings | 14.30 |
| EV / Sales | 0.66 |
| EV / EBITDA | 6.70 |
| EV / EBIT | 8.32 |
| EV / FCF | 17.66 |
Financial Position
The company has a current ratio of 1.32, with a Debt / Equity ratio of 1.77.
| Current Ratio | 1.32 |
| Quick Ratio | 0.60 |
| Debt / Equity | 1.77 |
| Debt / EBITDA | 3.56 |
| Debt / FCF | 9.38 |
| Interest Coverage | 3.44 |
Financial Efficiency
Return on equity (ROE) is 26.91% and return on invested capital (ROIC) is 9.99%.
| Return on Equity (ROE) | 26.91% |
| Return on Assets (ROA) | 7.75% |
| Return on Invested Capital (ROIC) | 9.99% |
| Return on Capital Employed (ROCE) | 19.11% |
| Revenue Per Employee | 3.35B |
| Profits Per Employee | 155.11M |
| Employee Count | 132 |
| Asset Turnover | 1.56 |
| Inventory Turnover | 6.16 |
Taxes
In the past 12 months, EASY BIO,Inc. has paid 7.13 billion in taxes.
| Income Tax | 7.13B |
| Effective Tax Rate | 25.37% |
Stock Price Statistics
The stock price has increased by +10.40% in the last 52 weeks. The beta is 0.90, so EASY BIO,Inc.'s price volatility has been similar to the market average.
| Beta (5Y) | 0.90 |
| 52-Week Price Change | +10.40% |
| 50-Day Moving Average | 5,261.20 |
| 200-Day Moving Average | 4,529.98 |
| Relative Strength Index (RSI) | 39.77 |
| Average Volume (20 Days) | 197,989 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, EASY BIO,Inc. had revenue of KRW 441.86 billion and earned 20.47 billion in profits. Earnings per share was 609.44.
| Revenue | 441.86B |
| Gross Profit | 106.41B |
| Operating Income | 35.20B |
| Pretax Income | 28.11B |
| Net Income | 20.47B |
| EBITDA | 43.68B |
| EBIT | 35.20B |
| Earnings Per Share (EPS) | 609.44 |
Balance Sheet
The company has 37.55 billion in cash and 155.51 billion in debt, giving a net cash position of -117.96 billion or -3,565.75 per share.
| Cash & Cash Equivalents | 37.55B |
| Total Debt | 155.51B |
| Net Cash | -117.96B |
| Net Cash Per Share | -3,565.75 |
| Equity (Book Value) | 88.06B |
| Book Value Per Share | 2,510.24 |
| Working Capital | 40.41B |
Cash Flow
In the last 12 months, operating cash flow was 19.21 billion and capital expenditures -2.64 billion, giving a free cash flow of 16.58 billion.
| Operating Cash Flow | 19.21B |
| Capital Expenditures | -2.64B |
| Free Cash Flow | 16.58B |
| FCF Per Share | 501.06 |
Margins
Gross margin is 24.08%, with operating and profit margins of 7.97% and 4.63%.
| Gross Margin | 24.08% |
| Operating Margin | 7.97% |
| Pretax Margin | 6.36% |
| Profit Margin | 4.63% |
| EBITDA Margin | 9.89% |
| EBIT Margin | 7.97% |
| FCF Margin | 3.75% |
Dividends & Yields
This stock pays an annual dividend of 200.00, which amounts to a dividend yield of 3.88%.
| Dividend Per Share | 200.00 |
| Dividend Yield | 3.88% |
| Dividend Growth (YoY) | 100.00% |
| Years of Dividend Growth | 2 |
| Payout Ratio | 16.67% |
| Buyback Yield | 1.60% |
| Shareholder Yield | 5.55% |
| Earnings Yield | 12.06% |
| FCF Yield | 9.77% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside |
Stock Splits
The last stock split was on December 21, 2020. It was a forward split with a ratio of 5.
| Last Split Date | Dec 21, 2020 |
| Split Type | Forward |
| Split Ratio | 5 |
Scores
EASY BIO,Inc. has an Altman Z-Score of 2.58 and a Piotroski F-Score of 5. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | 2.58 |
| Piotroski F-Score | 5 |